Laura Pizzi

Chief Science Officer

Dr Laura Pizzi is the Chief Science Officer for ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), the leading global professional society in the field of HEOR. In this role, she provides strategic scientific leadership, overseeing the organization’s major initiatives, including the development of ISPOR’s science strategy, content priorities, and global initiatives such as Special Interest Groups, the Patient Council, regional Patient Representative Roundtables, Health Technology Assessment (HTA) Roundtables, and the organization’s AI and Digital Health member initiatives.

Her team is also responsible for engaging with global healthcare authorities to support the use of HEOR in healthcare decision making. With a strong passion for education, Dr Pizzi co-led the development of ISPOR ’s first Health Economics and Outcomes Research Competency Framework, which outlines the core knowledge and skills essential to the HEOR profession.

Dr Pizzi brings more than 25 years of academic and research expertise to ISPOR. She has led multidisciplinary teams of methodologists, statisticians, and clinicians in designing and conducting cost and outcomes analyses for both pharmacologic therapies and non-pharmacologic interventions. Much of her work has focused on improving the quality of and access to treatments for older adults in underrepresented communities for diseases of aging such as dementia, diabetes, chronic vision diseases, and vaccine-preventable illness.

Her achievements include leading health economic analyses for numerous multicenter clinical trials, testifying before the US House of Representatives Committee on Ways and Means on Medicare spending, authoring a textbook on economic evaluation, and publishing more than 100 peer-reviewed manuscripts and 120 research presentations